ArticleBMC urology2020
Superselective embolization for high-flow priapism refractory to medical and surgical treatments.
Article in BMC urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU Sexual and Reproductive Health Guidelines panel.International journal of impotence research · 2024Pooled it
- Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND study.International journal of impotence research · 2026Article
- Super-selective arterial embolization in the therapy of non-ischemic priapism-a single-center study and literature review.CVIR endovascular · 2026Article
- Long-term outcomes of superselective transcatheter embolization in high-flow priapism.International journal of impotence research · 2026Article
- [High-flow priapism without a history of trauma: A case report].Revista medica del Instituto Mexicano del Seguro Social · 2025Article
- Posttraumatic high-flow priapism: a case of bilateral cavernous pseudoaneurysm irrigated by the right internal pudendal artery.BMC urology · 2025Article
- Successful Management of Recurrent High-Flow Priapism Treated with Selective Arterial Embolization: A Case Report.Journal of radiology case reports · 2023Article
- High-flow post-traumatic priapism with delayed presentation.BMJ case reports · 2022Article
- Effectiveness of Super-selective Embolization for Parasagittal Meningiomas and Its Effect on the Level of Inflammatory Factors.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThis study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments.
methodsFrom August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and their charts were retrospective reviewed. Clinical evaluation, color Doppler ultrasonography, arteriography and selective embolization were performed. Follow up was performed in all patients. Fourteen men (18-63 years old) were enrolled, with priapism duration of 14 h to 28 days. Internal pudendal arteries or glutaea inferior arteriae were successfully embolized with gelatin sponge particles, polyvinyl alcohol particles or microcoils.
resultsPseudoaneurysm in right femoral artery was found in one case after intervention. The follow-up 1 week later showed that 13 patients were in good condition, the priapism diminished 1-7 days (mean 3.2 ± 0.5 days) after intervention, and 1 patient received second intervention. Mean follow-up was (range 10.8-69.6) months. One patient had recurrent priapism months after embolization and had his penis surgically removed for severe necrosis.
conclusionsSuperselective embolization is safe and effective in high-flow priapism refractory local treatments, with a good long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.